BerganKDV Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$143K Sell
2,229
-151
-6% -$10.1K 0.01% 257
2023
Q1
$165K Buy
2,380
+390
+20% +$27.5K 0.02% 250
2022
Q4
$143K Buy
1,990
+375
+23% +$28.3K 0.02% 267
2022
Q3
$115K Sell
1,615
-844
-34% -$61.2K 0.01% 273
2022
Q2
$189K Sell
2,459
-49
-2% -$3.73K 0.02% 243
2022
Q1
$183K Sell
2,508
-236
-9% -$15.8K 0.02% 247
2021
Q4
$171K Buy
2,744
+255
+10% +$15K 0.02% 276
2021
Q3
$147K Buy
2,489
+3
+0.1% +$198 0.02% 275
2021
Q2
$166K Buy
2,486
+10
+0.4% +$652 0.02% 260
2021
Q1
$156K Sell
2,476
-418
-14% -$26K 0.02% 260
2020
Q4
$180K Buy
2,894
+523
+22% +$32.2K 0.03% 229
2020
Q3
$143K Buy
2,371
+17
+0.7% +$1.02K 0.02% 238
2020
Q2
$138K Sell
2,354
-19
-0.8% -$1.14K 0.02% 247
2020
Q1
$132K Buy
2,373
+853
+56% +$52.1K 0.03% 234
2019
Q4
$98K Buy
1,520
+320
+27% +$18.3K 0.02% 276
2019
Q3
$61K Sell
1,200
-420
-26% -$19.7K 0.01% 312
2019
Q2
$73K Sell
1,620
-2,280
-58% -$106K 0.01% 292
2019
Q1
$186K Buy
3,900
+2,500
+179% +$125K 0.04% 212
2018
Q4
$73K Buy
1,400
+200
+17% +$10.7K 0.02% 265
2018
Q3
$74K Sell
1,200
-15
-1% -$890 0.02% 281
2018
Q2
$67K Buy
+1,215
New +$65.6K 0.02% 286

Other funds holding BMY

BerganKDV Wealth Management's BMY Position: Q2 2023 in Review

BerganKDV Wealth Management reduced its Bristol-Myers Squibb (BMY) stake by 6.3% in Q2 2023, selling an estimated $10.1K and leaving 2,229 shares worth $143K. The position accounts for 0.01% of the portfolio, ranked #257.

BerganKDV Wealth Management first reported a position in BMY in Q2 2018 and has held it in 21 quarters since. The position peaked at $189K in Q2 2022. 2,480 funds tracked by Wall St. Rank hold BMY as of Q2 2023.

  • BerganKDV Wealth Management held 2,229 shares of Bristol-Myers Squibb worth $143K as of Q2 2023.
  • BerganKDV Wealth Management sold 151 Bristol-Myers Squibb shares in Q2 2023, an estimated $10.1K.
  • Bristol-Myers Squibb made up 0.01% of BerganKDV Wealth Management's portfolio in Q2 2023, its #257 holding.
  • BerganKDV Wealth Management first reported a position in Bristol-Myers Squibb in Q2 2018 and has held it in 21 quarters since.
  • BerganKDV Wealth Management's Bristol-Myers Squibb position peaked at $189K in Q2 2022.
  • 2,480 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2023.

Based on BerganKDV Wealth Management's 13F filing for Q2 2023, filed 24 Jul 2023.